Clofazimine (Clofazimine) side effects and corresponding treatment methods

Clofazimine (Clofazimine) is a broad-spectrum antibiotic mainly used to treat leprosy, leprosy reactions and some drug-resistant mycobacterial infections. Although it has significant antibacterial effects, clofazimine may cause some side effects when treating diseases such as leprosy, so it is important to understand its side effects and how to deal with them accordingly.

One of the most common side effects is a skin reaction, specifically a change in skin coloration. Clofazimine has a strong pigmentation effect, and patients may experience yellowing or red discoloration of the skin and conjunctiva of the eyes during use. This pigmentation is usually harmless and will gradually subside when the medication is stopped or treatment ends. But for some patients, this may affect appearance, especially with long-term treatment.

In addition, gastrointestinal reactions are also one of the common side effects of clofazimine treatment. Patients may experience nausea, vomiting, diarrhea, and abdominal pain. These reactions are generally mild, but if symptoms are severe, patients can alleviate discomfort by adjusting their diet, taking anti-GI medications, or spreading their medication around.

Liver damage is also a concern. Although liver injury is rare, some patients who take clofazimine for a long time may develop abnormal liver function, manifested by increased aminotransferase levels. In such cases, regular monitoring of the patient's liver function, especially liver enzyme levels, is recommended. If significant elevations occur, discontinuation of the drug and appropriate treatment should be considered.

Vision problems are also a possible side effect of clofazimine. Some patients may report blurred vision or eye discomfort, although these symptoms are less common. If patients develop vision problems during treatment, they should seek medical attention promptly to evaluate whether it is related to the use of clofazimine and consider whether to adjust the treatment plan.

Reference materials:https://www.novartis.com/our-products/pipeline/clofazimine